JONATHAN DUSKIN - 10 Jun 2022 Form 4 Insider Report for Citi Trends Inc (CTRN)

Role: Director
Signature: /s/ Jonathan Duskin
Issuer symbol: CTRN
Transactions as of: 10 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Jun 2022, 15:37:37 UTC
Previous filing: 10 Jan 2022
Next filing: 13 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTRN	Common Stock, $0.01 par value	Award	$0	+3,023	+36%	$0.000000	11,317	10 Jun 2022	Direct	F1
holding	CTRN	Common Stock, $0.01 par value						57,396	10 Jun 2022	By Macellum SPV III, LP	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of restricted stock awarded to Mr. Duskin in his capacity as a director of the Issuer. The restricted stock will vest on the earlier of (i) one year after the date of grant, which would be June 10, 2023 or (ii) the date of the annual meeting of the Company's stockholders in 2023, provided Mr. Duskin is a director of the Issuer at such time.
F2	Represents securities of the Issuer owned directly by Macellum SPV III, LP ("Macellum SPV"). Macellum Management, LP ("Macellum Management") serves as the investment manager of Macellum SPV. Macellum Advisors GP, LLC ("Macellum GP") serves as the general partner of Macellum Management and Macellum SPV. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities of the Issuer owned directly by Macellum SPV. Mr. Duskin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Content

Represents shares of restricted stock awarded to Mr. Duskin in his capacity as a director of the Issuer. The restricted stock will vest on the earlier of (i) one year after the date of grant, which would be June 10, 2023 or (ii) the date of the annual meeting of the Company's stockholders in 2023, provided Mr. Duskin is a director of the Issuer at such time.

Represents securities of the Issuer owned directly by Macellum SPV III, LP ("Macellum SPV"). Macellum Management, LP ("Macellum Management") serves as the investment manager of Macellum SPV. Macellum Advisors GP, LLC ("Macellum GP") serves as the general partner of Macellum Management and Macellum SPV. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities of the Issuer owned directly by Macellum SPV. Mr. Duskin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.